April 8, 2021
A key health ministry advisory panel will discuss whether to recommend approval for MSD’s antibiotic known as Recarbrio overseas, which combines relebactam, imipenem, and cilastatin, at its meeting on April 21. If given the nod, the drug could land approval...read more